LSPN925
LSPN925 is an anticancer agent. LSPN925 exhibits cytotoxic and antiproliferative activities against tumor cells. LSPN925 has predicted oral bioavailability, low risks of hepatotoxicity and acute toxicity, and no risk of cardiotoxicity. LSPN925 can be used for the research of ovarian cancer, melanoma and breast cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C24H22N2O6
- Masse moléculaire:434.44
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
LSPN925 (48 h) inhibits the viability of A2780, A375 and MCF-7 cancer cells[1].
LSPN925 (48 h) alters the morphology and reduces the viability of A2780 ovarian cancer cells, as evidenced by increased membrane damage and decreased cell density[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A2780 ovarian cancer cells, A375 human melanoma cells, MCF-7 breast cancer cells, MRC-5 non-cancerous lung cells
-
Concentration:/
-
Incubation Time:48 h
-
Result:Exhibited dose-dependent cytotoxicity against A2780, A375, and MCF-7 cancer cell lines, with IC50 values of 29.59 μM, 65.15 μM, and 81.20 μM, respectively.
Showed no significant cytotoxicity in non-cancerous MRC-5 cells (IC50 > 100 μM).
Chemical Information
-
Masse moléculaire 434.44
-
Formule C24H22N2O6
-
SMILES
CC1=CC=C(OC(C(C(N2)=C(C(OCC)=O)C(C3=CC(OC)=CC=C3)NC2=O)=C4)=O)C4=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)